Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• The tumor microenvironment (TME) significantly influences cancer progression.
• Cancer-associated fibroblasts (CAFs) are key regulators within the TME, impacting tumor cell proliferation, metastasis, and treatment resistance.
• Advanced prostate cancer (PCa) poses challenges due to resistance to therapies like androgen deprivation therapy (ADT).

Purpose of the Study:

• To systematically review the signaling pathways and molecular mechanisms by which CAFs promote PCa progression.
• To evaluate the utility of CAFs as prognostic biomarkers in prostate cancer.
• To discuss novel therapeutic targets and intervention strategies focused on CAFs for treating advanced PCa.

Main Methods:

• Systematic literature review of recent discoveries.
• Analysis of signaling pathways and molecular interactions between CAFs and PCa cells.
• Evaluation of existing research on CAFs as prognostic markers and therapeutic targets.

Main Results:

• CAFs employ diverse mechanisms to foster PCa growth, metastasis, and resistance.
• Specific signaling pathways and molecular interactions driving CAF-mediated PCa progression have been identified.
• CAFs show potential as prognostic biomarkers for prostate cancer outcomes.

Conclusions:

• Understanding CAF-PCa cell interactions is critical for advancing prostate cancer treatment.
• Targeting CAFs presents a promising therapeutic avenue for overcoming resistance in advanced prostate cancer.
• Further research into CAF-based strategies could lead to improved patient outcomes.